A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma
Clinical trial NCT02623127 · COMPLETED
Trial details
- NCT number
- NCT02623127
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-12-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.